CIK: 0001440771 · Show all filings
Period: Q4 2015 (Next →)
Filing Date: Feb 11, 2016
Total Value ($000): $85,361 (100.0% shares, 0.0% debt)
| Ticker | Issuer | Shares | Value ($000) | % | Est. Cost | Unrealized | Class | CUSIP |
|---|---|---|---|---|---|---|---|---|
| VNDA | VANDA PHARMACEUTICALS INC | 1,918,929 | $17,865 | 20.9% | $9.98 | 0.0% | COM | 921659108 |
| — | CTI BIOPHARMA CORP | 10,698,618 | $13,159 | 15.4% | $1.23 | — | COM | 12648L106 |
| — | SCICLONE PHARMACEUTICALS INC | 1,175,574 | $10,815 | 12.7% | $9.20 | — | COM | 80862K104 |
| — | TOBIRA THERAPEUTICS INC | 833,377 | $8,375 | 9.8% | $10.05 | — | COM | 88883P101 |
| — | SAGENT PHARMACEUTICALS INC | 462,824 | $7,364 | 8.6% | $15.91 | — | COM | 786692103 |
| — | PERNIX THERAPEUTICS HOLDINGS | 2,484,649 | $7,330 | 8.6% | $2.95 | — | COM | 71426V108 |
| — | PAIN THERAPEUTICS INC | 3,575,000 | $6,256 | 7.3% | $1.75 | — | COM | 69562K100 |
| — | FOUNDATION MEDICINE INC | 173,049 | $3,644 | 4.3% | $21.06 | — | COM | 350465100 |
| VCEL | VERICEL CORP | 1,376,887 | $3,552 | 4.2% | $2.24 | 0.0% | COM | 92346J108 |
| ENTA | ENANTA PHARMACEUTICALS INC | 71,147 | $2,349 | 2.8% | $32.59 | 0.0% | COM | 29251M106 |
| — | DERMA SCIENCES INC | 507,799 | $2,321 | 2.7% | $4.57 | — | COM | 249827502 |
| — | CUTERA INC | 100,000 | $1,279 | 1.5% | $12.79 | — | COM | 232109108 |
| — | RECRO PHARMA INC | 116,901 | $1,052 | 1.2% | $9.00 | — | COM | 75629F109 |